Free Trial

Production Of COVID-19 Vaccine To Start In 2 Weeks

RUSSIA

Russian state-owned news outlet TASS is citing Health Minister Mikhail Murashko that the country will begin producing the COVID-19 vaccine that was given regulatory approval on August 11 within 2 weeks.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.